NDC 68000-108-06 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 68000-108
- Requested NDC
- 68000-108-06
- Package NDCs from labels
- 68000-108-06, 68000-108-05
- Manufacturer
- American Health Packaging
- Effective date
- 2026-05-22
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam - American Health Packaging | American Health Packaging | 2026-05-22 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Hospira, Inc. | 20140b19-846b-425f-b191-670e17809945 | 2026-07-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | d6364be4-056b-4ebe-83bc-3fc85e8f488c | 2026-07-09 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | St. Mary's Medical Park Pharmacy | 56093df3-10f6-e747-e063-6294a90a6564 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | St. Mary's Medical Park Pharmacy | 569e8a5a-ddf7-ebbc-e063-6294a90ab7a4 | 2026-07-07 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | b707ecb2-644c-4323-ab0e-7bc5929cd560 | 2026-06-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Unit Dose Solutions, Inc. | 5519bba8-9eb7-a3e0-e063-6294a90afd94 | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Unit Dose Solutions, Inc. | 551a1b7f-d342-2c53-e063-6394a90a9a2a | 2026-06-25 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | REMEDYREPACK INC. | 0cd02e52-ead5-4b2a-9708-c7c4be7b7995 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Coupler LLC | 54d72943-f8d1-5a78-e063-6294a90a059b | 2026-06-22 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Redpharm Drug | 5407f327-3a22-8c15-e063-6294a90a3169 | 2026-06-12 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| LORAZEPAM | LORAZEPAM | REMEDYREPACK INC. | 7fa1a011-5e28-4b13-bcd2-5c5fc9b663b2 | 2026-06-10 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| LORAZEPAM | LORAZEPAM | Bryant Ranch Prepack | 46af8e93-3169-408a-b4d8-b8498642801d | 2026-06-05 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Preferred Pharmaceuticals Inc. | 4a50329b-b272-4164-bddf-0d6cea3d7a23 | 2026-05-29 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Redpharm Drug | 52614947-c96c-3361-e063-6394a90ae172 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | American Health Packaging | 6dfbe8be-168c-44e9-acfa-fa838b92d3b7 | 2026-05-22 | Boxed warning, Warnings, Adverse reactions | ANDA090260 68000-108-06 68000-108-05 68000-107-06 68000-107-05 68000-108 68000-107 68000010806 311376 526d506c-6cb1-29c5-e063-6394a90aafae 6dfbe8be-168c-44e9-acfa-fa838b92d3b7 O26FZP769L |
| Lorazepam | LORAZEPAM | Bryant Ranch Prepack | 11372b3d-52c0-4694-8c88-4b72d3fda9d0 | 2026-05-14 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Coupler LLC | 51119efa-c1a3-71f0-e063-6394a90a9e2a | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Coupler LLC | 5114810c-025f-6113-e063-6294a90af538 | 2026-05-05 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Fresenius Kabi USA, LLC | 462a13da-259a-40e7-bd5b-f7f42ae025b7 | 2026-03-13 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| LORAZEPAM | LORAZEPAM | PD-Rx Pharmaceuticals, Inc. | 0418ad09-3069-4381-9a8f-e41b234fdac6 | 2026-02-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.